GCP Video Series: Risk Assessment Monitoring

ClinOps Toolkit interview with Penelope Manasco Mana Consulting RBM

Risk Assessment Monitoring Assures Quality Clinical Trial Outcomes When monitoring clinical trials with a risk-based monitoring (RBM) approach, how do you determine Key Performance Indicators (KPIs)? How do you identify where the high-risk areas are? How can you assess them? How can you learn how to evaluate and interpret data? What kinds of things you…

Continue Reading →

Secret Formula to be the Best Clinical Trial Site

The Best Clinical Trial Sites are Empowered The best clinical trial sites have laser-focus on the ultimate goal to advance treatment options for their patients. The best sites perform all trial activities and procedures with the highest attention to quality and adherence.  Sponsors will reward for this performance and clamor to work with these sites again…

Continue Reading →

Medidata Talks RBM with ClinOps Toolkit for SCOPE2015 Conference

Medidata Talks RBM Big data is being generated by everything around us at all times. Every digital process and social media exchange produces it, including clinical trials. Harnessing the power of big data analytics is the latest advancement in RBM. Barbara’s talk gave practical examples on implementing RBM and extolled the benefits of how all…

Continue Reading →

Introducing the GCP Video Series by ClinOps Toolkit

GCP Video Series I am delighted to announce the GCP Video Series by ClinOps Toolkit.  Here, GCP stands for Good Clinical Professionals!  We have filmed two interview style videos already and I have filmed two vlogger style videos.  It has been a lot of fun learning more about this medium for communicating with you all.…

Continue Reading →

How do you build meaningful relationships with your network?

Cultivating Meaningful Relationships Support from my network makes me more successful I’m so grateful for meaningful relationships with like-minded people who believe in me. When I am stuck or need help I can always find someone who not only understands my needs but wants to help me overcome obstacles and achieve more. As I have…

Continue Reading →

Text Messaging in Clinical Trial Patient Recruiting and Retention

Text and Drugs The Power of Text Messaging in Clinical Trial Patient Recruiting and Retention Mosio’s Co-Founder and CTO, Jay Sachdev, will be presenting in a master class on patient recruiting at the upcoming MAGI West Conference in San Francisco, CA (November 9 – 12, 2014). Those familiar with the challenges in patient recruiting will…

Continue Reading →

Trends in Clinical Trial Data

The clinical trial world is experiencing a considerable increase in the quantity of available clinical data. In this video from the June 2014 ClinOps Toolkit meetup event, Marc Desgrousilliers, CTO of Clinovo delves into emerging trends in clinical trial data.  Most importantly, the increasing quantity of patient and clinical trial data (more sources, more complexity,…

Continue Reading →

Six “Easy Wins” to Immediately Improve Clinical Trials Financial Forecasts

Six “Easy Wins” to Immediately Improve Clinical Trials Financial Forecasts As you’re busy trying to initiate sites, manage enrollment, and meet trial targets, those momentum-interrupting party-poopers in Finance demand another financial reforecast; the very same folks who, months later, will demand to know why your forecast numbers were so far off. No one disputes that…

Continue Reading →

Six Strategies to be a More Effective Monitor

Become a More Effective Monitor Six Strategies to be a More Effective Monitor On-Demand Webinar by Patty Kasper, MS, CCRA When I first became a CRA, I took a course led by expert in clinical monitoring, Patty Kasper, MS, CCRA. Today, almost a decade later, I still regularly reference the materials and Patty’s straightforward methods for…

Continue Reading →

Back on my RBM Soapbox

Time for another installment of Nadia’s RBM Soapbox More from Transcelerate this week on the Risk-Based Monitoring (RBM Methodology).  Check out the July update here. As an industry, we absolutely need more conversations about quality, oversight, completeness, and appropriate monitor expectations.  So don’t get me wrong, I love dialogue on this and many other topics.…

Continue Reading →